02/19/2026
🔁 Resharing for awareness 🧬
We know many in the scleroderma community are interested in learning more about CAR-T cell therapy and ongoing clinical trials. Novartis has launched a page with information about research and trials in this evolving area.
While we do not endorse specific clinical trials or studies, we share updates to help keep our community informed. You can also stay current on trial news by subscribing to our Clinical Trials Connections newsletter.
We know many in the scleroderma community are eager to learn more about CAR-T cell therapy and clinical trials. 🧬
Novartis has recently launched a new page to share insights about trials in this exciting area of research: https://ow.ly/3T9E50YcOmH
The Foundation does not endorse clinical trails or studies, but we do share information to keep our community informed.
Keep up to date with the latest news in clinical trials by subscribing to our Clinical Trials Connections newsletter: https://ow.ly/Gg7e50YcOmJ